Nuvation Bio Inc. Amortization
Nuvation Bio Inc. (NUVB) reported Amortization of $3.00 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2021-11-10
- Nuvation Bio Inc. amortization for the quarter ending 2021-09-30 was $1.30M, a 1200.00% increase year-over-year.
- Nuvation Bio Inc. amortization for the quarter ending 2021-06-30 was $1.10M, a 1000.00% increase year-over-year.
- Nuvation Bio Inc. amortization for the quarter ending 2021-03-31 was $600.00K, a 200.00% increase year-over-year.
- Nuvation Bio Inc. amortization for the quarter ending 2020-09-30 was $100.00K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month |
|---|---|---|---|
| 2021-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.40M derived: sum of 2 quarters · filed 2021-11-10 | $3.00M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.70M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $600.00K 10-Q · filed 2021-05-17 | ||
| 2020-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $200.00K derived: sum of 2 quarters · filed 2021-11-10 | $400.00K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $300.00K 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |